The lower median time until start of insulin observed in patients aged 18 to 39 years compared to those aged 40 years and over might mean that some patients with T1DM were misclassified as patients with T2DM although it may also suggest those with early-onset disease progress faster. The gene discussed is INS; the disease is type 1 diabetes mellitus.